SLPMeta-AnalysisAutism research : official journal of the International Society for Autism Research2025

Eye Tracking as a Treatment Monitoring Tool for Autism: A Multilevel Meta-Analysis.

Christy D Yoon, Yan Xia, Adriana Kaori Terol and 2 others

PMID 41235721

WHAT IT FOUND

Eye-tracking measures showed small, significant changes after autism interventions, suggesting they can track treatment effects.

However, baseline eye-tracking did not significantly predict later developmental gains, meaning it cannot currently be used to forecast how well a specific child will respond to therapy.

Key findings

01There was a modest, significant summary effect size for changes in eye-tracking outcomes from pre- to post-treatment.

02The analysis revealed a moderate, non-significant summary effect size for the correlation between baseline eye-tracking outcomes and changes in developmental outcomes.

03Changes in eye-tracking outcomes were significant for dynamic stimuli (videos) but not for static stimuli (images).

STILL TO COME

How it was doneWhat they foundWhat it means for SLPs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The analysis for predicting treatment response was exploratory and based on a small number of studies (39 effect sizes), limiting its robustness. There is no established Minimal Clinically Important Difference (MCID) for eye-tracking measures in autism, making it difficult to judge if the observed changes are functionally meaningful. The study did not include backward or forward searches of references, which may have missed relevant data. Grouping treatments into broad categories (e.g., behavioral, biomedical) may have oversimplified complex intervention mechanisms. High heterogeneity (I² > 70%) was observed across studies, indicating variability in how effects were measured and reported.

Declared interests

Frederick Shic is or has been a consultant for MindMed Inc., Janssen Pharmaceuticals, and Roche Ltd. The work was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the University of Wisconsin-Madison.

The easy way to misread this

Do not interpret the significant change in eye-tracking outcomes as evidence that the intervention improved social functioning. The study notes that these gaze changes are incremental and their translation to functional gains in daily life remains uncertain, especially since baseline eye-tracking did not significantly predict developmental outcomes.

Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →